Peter P. Pfreundschuh has an estimated net worth of $1.31 Million. This is based on reported shares across multiple companies, which include IMMUNOMEDICS INC, Sucampo Pharmaceuticals, Inc., UroGen Pharma Ltd., Frequency Therapeutics, Inc., Voyager Therapeutics, Inc., and Y-mAbs Therapeutics, Inc..

2020 was Peter P. Pfreundschuh's most active year for acquiring shares with 10 total transactions. Peter P. Pfreundschuh's most active month to acquire stocks was the month of December. 2020 was Peter P. Pfreundschuh's most active year for disposing of shares, totalling 18 transactions. Peter P. Pfreundschuh's most active month to dispose stocks was the month of January. 2017 saw Peter P. Pfreundschuh paying a total of $3,585.40 for 150,394 shares, this is the most they've acquired in one year. In 2018 Peter P. Pfreundschuh cashed out on 150,263 shares for a total of $1,069,734.00, their largest year based on trade value.